Greater Glasgow and Clyde Medicines
Key to symbols The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP The medicine should only be used and prescribed by a specialist Indicates the preferred choice within a class or group of medicines
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
7.5. Drugs used in Chronic Kidney Disease

7.5.3. Cation exchange compound

Total Formulary
Specialist and GP
PATIROMER (VELTASSA) (oral suspension)

Restrictions:

Restricted to specialist initiation in patients with hyperkalaemia (serum potassium >6.0mmol/L) with chronic kidney disease (CKD) stage 3b to 5 and/or heart failure who would otherwise need to downtitrate or discontinue their renin-angiotensin-aldosterone system inhibitor (RAASi) therapy to maintain a clinically acceptable serum potassium level.

Prescribing Notes:

Please refer to section 9.2.1.1 for treatment of acute, life-threatening hyperkalaemia.

BNF Link

Specialist and GP
SODIUM ZIRCONIUM CYCLOSILICATE (LOKELMA)

Restrictions:

Restricted to specialist initiation in patients with hyperkalaemia (serum potassium >6.0mmol/L) with chronic kidney disease (CKD) stage 3b to 5 and/or heart failure who would otherwise need to down-titrate or discontinue their renin-angiotensin-aldosterone system inhibitor (RAASi) therapy to maintain a clinically acceptable serum potassium level. 

Prescribing Notes:

Please refer to section 9.2.1.1 for treatment of acute, life-threatening hyperkalaemia.

BNF Link